The Evolving Personalized Landscape of Colorectal Cancer Therapies

Affiliations

¹ Division of Radiation Oncology, University of Vermont Larner College of Medicine, Burlington, Vermont.
² Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
³ Department of Radiation Oncology, Miami Cancer Institute, Miami, Florida.
⁴ University College London, London, United Kingdom.
⁵ Department of Radiation Oncology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
⁶ Department of Radiation Oncology, University of California, Los Angeles, CA.
⁷ Department of Clinical Oncology (GI), The Royal Marsden NHS Foundation Trust, London, United Kingdom.
⁸ Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado. Electronic address: Jeffrey.R.Olsen@CUAnschutz.edu.

Editorial

Christopher J Anker et al. Int J Radiat Oncol Biol Phys. 2021.

. 2021 Aug 1;110(5):1255-1262.

doi: 10.1016/j.ijrobp.2021.03.016.

¹ Division of Radiation Oncology, University of Vermont Larner College of Medicine, Burlington, Vermont.
² Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
³ Department of Radiation Oncology, Miami Cancer Institute, Miami, Florida.
⁴ University College London, London, United Kingdom.
⁵ Department of Radiation Oncology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
⁶ Department of Radiation Oncology, University of California, Los Angeles, CA.
⁷ Department of Clinical Oncology (GI), The Royal Marsden NHS Foundation Trust, London, United Kingdom.
⁸ Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado. Electronic address: Jeffrey.R.Olsen@CUAnschutz.edu.

No abstract available

Comment on

Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
Rullier E, Vendrely V, Asselineau J, Rouanet P, Tuech JJ, Valverde A, de Chaisemartin C, Rivoire M, Trilling B, Jafari M, Portier G, Meunier B, Sieleznieff I, Bertrand M, Marchal F, Dubois A, Pocard M, Rullier A, Smith D, Frulio N, Frison E, Denost Q. Rullier E, et al. Lancet Gastroenterol Hepatol. 2020 May;5(5):465-474. doi: 10.1016/S2468-1253(19)30410-8. Epub 2020 Feb 7. Lancet Gastroenterol Hepatol. 2020. PMID: 32043980 Clinical Trial.
Avoidance of Overtreatment of Rectal Cancer by Selective Chemoradiotherapy: Results of the Optimized Surgery and MRI-Based Multimodal Therapy Trial.
Ruppert R, Kube R, Strassburg J, Lewin A, Baral J, Maurer CA, Sauer J, Junginger T, Hermanek P, Merkel S; other members of the OCUM Group. Ruppert R, et al. J Am Coll Surg. 2020 Oct;231(4):413-425.e2. doi: 10.1016/j.jamcollsurg.2020.06.023. Epub 2020 Jul 19. J Am Coll Surg. 2020. PMID: 32697965
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
André T, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, Smith D, Garcia-Carbonero R, Benavides M, Gibbs P, de la Fouchardiere C, Rivera F, Elez E, Bendell J, Le DT, Yoshino T, Van Cutsem E, Yang P, Farooqui MZH, Marinello P, Diaz LA Jr; KEYNOTE-177 Investigators. André T, et al. N Engl J Med. 2020 Dec 3;383(23):2207-2218. doi: 10.1056/NEJMoa2017699. N Engl J Med. 2020. PMID: 33264544 Clinical Trial.